Trazodone promotes sleep by blocking three types of receptors in the brain that regulate wakefulness and arousal. Originally developed as an antidepressant in the 1980s, it’s now used far more often for insomnia. In 2019, roughly 74% of all trazodone prescriptions in the United States were written specifically for sleep disorders, totaling about 20 million prescriptions that year alone.
The Three Receptors Behind the Sedation
At the low doses typically used for sleep, trazodone occupies three key receptor types almost completely. A pharmacological analysis from King’s College London estimated the occupancy rates at a standard sleep dose: 97% of serotonin 2A receptors, 88% of a specific type of adrenaline receptor, and 84% of histamine receptors. Each of these contributes to sedation in a different way.
Blocking serotonin 2A receptors is the biggest piece of the puzzle. These receptors normally promote wakefulness and light sleep. When trazodone shuts them down, it becomes easier to fall asleep and to reach deeper stages of sleep. Blocking adrenaline receptors dampens the body’s alertness signaling, which is why trazodone can also reduce anxiety at bedtime. And blocking histamine receptors works through the same general pathway as antihistamines like diphenhydramine (the active ingredient in many over-the-counter sleep aids), producing drowsiness directly.
This triple mechanism is why trazodone can feel noticeably sedating even at doses far below what’s needed for its antidepressant effect. The receptors responsible for sleepiness are almost fully occupied before the serotonin reuptake effects that treat depression even begin to kick in.
Sleep Doses vs. Antidepressant Doses
The dose gap between sleep use and depression treatment is significant. For insomnia, most people start at 25 to 50 mg taken at bedtime, with 50 to 100 mg being the most common effective range. The ceiling for sleep use is around 200 mg. For depression, the starting dose is 150 mg per day, and the typical therapeutic range is 200 to 400 mg daily, sometimes reaching 600 mg for hospitalized patients.
This means the sleep dose is roughly one-quarter to one-half of the lowest antidepressant dose. At these lower amounts, the receptor-blocking effects dominate while the serotonin-boosting properties remain minimal. That’s also why side effects tend to be milder when trazodone is used for sleep compared to its use as an antidepressant.
How It Affects Sleep Quality
Trazodone doesn’t just help you fall asleep. It changes the structure of your sleep in ways that generally improve quality. In a controlled study published in Frontiers in Psychiatry, people taking trazodone spent more time in deep sleep (the restorative stage known as N3 or slow-wave sleep) and less time in the lightest stage of sleep. They also woke up less often during the night, and their overall sleep efficiency improved compared to placebo.
Notably, trazodone did not significantly change the amount of REM sleep. This is a meaningful distinction from many other sleep medications, including benzodiazepines and some newer sleep drugs, which tend to suppress REM. Preserving REM sleep matters because it plays a role in memory consolidation and emotional regulation. For people who want to sleep better without disrupting their natural sleep cycles, this is one of trazodone’s practical advantages.
How Quickly It Works
Trazodone reaches its peak concentration in the blood about one hour after you take it on an empty stomach, or about two hours if you’ve recently eaten. Most people feel drowsy within 30 to 60 minutes. Because of this, it’s typically taken right at bedtime rather than earlier in the evening.
The drug’s half-life ranges from 5 to 13 hours, meaning it takes that long for your body to clear half the dose. For most people taking a low sleep dose, the sedation wears off by morning. But on the longer end of that range, or at higher doses, some people experience grogginess the next day, especially when they first start taking it.
Common Side Effects at Sleep Doses
The same adrenaline-receptor blocking that helps with sleep also affects blood pressure regulation. Trazodone can cause orthostatic hypotension, a drop in blood pressure when you stand up quickly. This can feel like lightheadedness or dizziness, and it’s more pronounced in older adults. Among nursing home residents, orthostatic hypotension from any cause affects 18% to 54% of the population, and medications like trazodone add to that risk. Standing up slowly, particularly during nighttime bathroom trips, is a practical way to reduce the chance of a fall.
Other common side effects at sleep doses include dry mouth, headache, and mild nausea. These tend to be most noticeable in the first week and often fade as your body adjusts.
One rare but serious side effect affects men specifically. Trazodone is associated with priapism, a painful erection lasting more than four hours that occurs without sexual stimulation. The incidence is estimated between 1 in 1,000 and 1 in 10,000. While uncommon, priapism is a medical emergency that requires immediate treatment to prevent permanent damage.
Drug Interactions to Be Aware Of
Trazodone is broken down in the liver by an enzyme called CYP3A4. Medications that inhibit this enzyme can cause trazodone to build up in your system to much higher levels than intended. In a study of 10 healthy volunteers, taking the antiviral ritonavir alongside a single 50 mg dose of trazodone increased trazodone’s peak blood level by 34% and its overall exposure by 2.4 times. Participants experienced nausea, low blood pressure, and fainting.
Antifungal medications like ketoconazole and itraconazole have similar potential. The FDA label specifically warns that combining trazodone with potent CYP3A4 inhibitors may increase the risk of heart rhythm problems. If you take any of these medications, a lower trazodone dose is typically needed.
Why Trazodone Is Prescribed Off-Label
Despite being one of the most commonly prescribed sleep aids in the country, trazodone has never been FDA-approved for insomnia. Its approval is only for major depressive disorder. This means every insomnia prescription is technically off-label. A 2024 analysis in Health Affairs Scholar found that at least 85% of all trazodone prescriptions, and about $247 million in annual spending, went toward off-label uses, primarily insomnia.
This off-label status doesn’t mean the use is unsupported. It reflects the fact that pharmaceutical companies haven’t pursued an insomnia-specific approval, likely because trazodone has been generic for decades and there’s little financial incentive to fund the required clinical trials. Clinicians continue to prescribe it for sleep because it works through well-understood mechanisms, carries a lower risk of dependence than benzodiazepines or Z-drugs like zolpidem, and has decades of real-world use behind it.